As the COVID vaccine started rolling out, Mike Donio, M.S., began recognizing that the methodology behind the vaccine is ‘very similar’ to a methodology he uses, but for lipid-based transfection, not vaccination.

“I saw it as a transfection methodology as opposed to just a vaccine,” Mike Donio explained. “Why would you want to do that to someone at this scale?”